| Date Filed | Type | Description |
| 06/09/2023 |
4
| Booth Bruce (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/08/2023 |
4
| Booth Bruce (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,643 options to buy
@ $1.09, valued at
$19.2k
|
|
| 01/13/2023 |
4
| Booth Bruce (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 21,683 shares
@ $29.96, valued at
$649.6k
Sold 6,071 shares
@ $29.96, valued at
$181.9k
Sold 77,128 shares
@ $30.29, valued at
$2.3M
Sold 21,592 shares
@ $30.29, valued at
$654k
|
|
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Booth Bruce (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $14.18, valued at
$170.2k
|
|
| 06/13/2022 |
4
| Booth Bruce (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 12,155 options to buy
@ $3.1, valued at
$37.7k
|
|
| 06/10/2022 |
4
| Booth Bruce (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,478 options to buy
@ $1.06, valued at
$18.5k
|
|
| 03/03/2022 |
4
| Booth Bruce (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 7,577 options to buy
@ $16.13, valued at
$122.2k
|
|
| 01/11/2022 |
4
| Booth Bruce (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Converted 2,831,520 shares
@ $0
Converted 1,027,978 shares
@ $0
Bought 535,000 shares
@ $14, valued at
$7.5M
Converted 7,852,374 preferred shares
@ $0
Converted 2,850,789 preferred shares
@ $0 |
|
| 01/06/2022 |
3
| Booth Bruce (Director) has filed a Form 3 on Vigil Neuroscience, Inc. |
| 08/12/2021 |
4
| Booth Bruce (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Sold 242,133 shares
@ $61, valued at
$14.8M
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Booth Bruce (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,438 options to buy
@ $9.63, valued at
$167.9k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Booth Bruce (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Bought 1,250,000 shares
@ $8, valued at
$10M
|
|
| 06/11/2020 |
4
| Booth Bruce (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 14,331 options to buy
@ $0.63, valued at
$9k
|
|
| 06/09/2020 |
4
| Booth Bruce (Director) has filed a Form 4 on Magenta Therapeutics, Inc.|
Txns:
| Granted 18,188 options to buy
@ $9.99, valued at
$181.7k
|
|
| 06/05/2020 |
4
| Booth Bruce (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 14,000 options to buy
@ $21.91, valued at
$306.7k
|
|
| 04/08/2020 |
4
| Booth Bruce (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 86,735 options to buy
@ $0.3495, valued at
$30.3k
|
|
| 01/06/2020 |
4
| Booth Bruce (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 39,996 options to buy
@ $0.72, valued at
$28.8k
|
|
| 10/03/2019 |
4
| Booth Bruce (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 20,611 options to buy
@ $1.41, valued at
$29.1k
|
|
| 07/23/2019 |
4
| Booth Bruce (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Bought 810,811 shares
@ $18.5, valued at
$15M
|
|
| 07/03/2019 |
4
| Booth Bruce (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 10,285 options to buy
@ $2.41, valued at
$24.8k
|
|
| 06/20/2019 |
4
| Booth Bruce (Director) has filed a Form 4 on Unum Therapeutics Inc.|
Txns:
| Granted 14,331 options to buy
@ $2.7, valued at
$38.7k
|
|
| 06/13/2019 |
4
| Booth Bruce (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 9,675 options to buy
@ $13.6, valued at
$131.6k
|
|
| 06/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|